Baillie Gifford & CO Dexcom Inc Transaction History

Baillie Gifford & CO

$131 Billion
Q3 2024

A detailed history of Baillie Gifford & CO transactions in Dexcom Inc stock. As of the latest transaction made, Baillie Gifford & CO holds 15,017,666 shares of DXCM stock, worth $1.15 Billion. This represents 0.77% of its overall portfolio holdings.

Number of Shares

15,017,666

Previous 15,325,931 2.01%

Holding current value

$1.15 Billion

Previous $1.74 Billion 42.08%

% of portfolio

0.77%

Previous 1.38%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$64.0 - $116.06 $19.7 Million - $35.8 Million	-308,265 Reduced 2.01%	15,017,666 $1.01 Billion
Q2 2024 Jul 25, 2024	SELL	$110.31 - $140.45 $40 Million - $50.9 Million	-362,465 Reduced 2.31%	15,325,931 $1.74 Billion
Q1 2024 May 01, 2024	SELL	$114.22 - $140.1 $95 Million - $117 Million	-831,917 Reduced 5.04%	15,688,396 $2.18 Billion
Q4 2023 Jan 26, 2024	SELL	$75.49 - $124.16 $12.2 Million - $20.1 Million	-162,191 Reduced 0.97%	16,520,313 $2.05 Billion
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $3.51 Million - $5.63 Million	-40,794 Reduced 0.24%	16,682,504 $1.56 Billion
Q2 2023 Jul 28, 2023	SELL	$112.47 - $130.98 $48.8 Million - $56.9 Million	-434,201 Reduced 2.53%	16,723,298 $2.15 Billion
Q1 2023 May 03, 2023	SELL	$104.0 - $122.92 $15.1 Million - $17.9 Million	-145,386 Reduced 0.84%	17,157,499 $1.99 Billion
Q4 2022 Jan 24, 2023	SELL	$84.98 - $122.67 $68.2 Million - $98.4 Million	-802,293 Reduced 4.43%	17,302,885 $1.96 Billion
Q3 2022 Oct 27, 2022	BUY	$76.35 - $94.18 $441,226 - $544,266	5,779 Added 0.03%	18,105,178 $1.46 Billion
Q2 2022 Aug 08, 2022	BUY	$67.99 - $132.89 $921 Million - $1.8 Billion	13,545,106 Added 297.41%	18,099,399 $1.35 Billion
Q1 2022 May 05, 2022	BUY	$94.08 - $130.2 $4.24 Million - $5.87 Million	45,107 Added 1.0%	4,554,293 $2.33 Billion
Q4 2021 Jan 20, 2022	SELL	$129.87 - $162.82 $109 Million - $137 Million	-840,632 Reduced 15.71%	4,509,186 $2.42 Billion
Q3 2021 Oct 19, 2021	BUY	$106.71 - $143.18 $14.2 Million - $19.1 Million	133,197 Added 2.55%	5,349,818 $2.93 Billion
Q2 2021 Aug 02, 2021	SELL	$80.99 - $107.93 $9.2 Million - $12.3 Million	-113,617 Reduced 2.13%	5,216,621 $2.23 Billion
Q1 2021 May 06, 2021	SELL	$84.79 - $104.74 $10.5 Million - $12.9 Million	-123,606 Reduced 2.27%	5,330,238 $1.92 Billion
Q4 2020 Feb 10, 2021	BUY	$78.0 - $104.5 $95.6 Million - $128 Million	1,225,388 Added 28.98%	5,453,844 $2.02 Billion
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $29.9 Million - $35.4 Million	-313,528 Reduced 6.9%	4,228,456 $1.74 Billion
Q2 2020 Aug 12, 2020	SELL	$62.68 - $105.34 $18.1 Million - $30.4 Million	-288,568 Reduced 5.97%	4,541,984 $1.84 Billion
Q1 2020 May 08, 2020	BUY	$47.79 - $75.63 $728,940 - $1.15 Million	15,253 Added 0.32%	4,830,552 $1.3 Billion
Q4 2019 Feb 10, 2020	SELL	$36.62 - $57.29 $367,005 - $574,160	-10,022 Reduced 0.21%	4,815,299 $1.05 Billion
Q3 2019 Nov 07, 2019	SELL	$35.53 - $43.8 $354,163 - $436,598	-9,968 Reduced 0.21%	4,825,321 $720 Million
Q2 2019 Aug 08, 2019	SELL	$27.84 - $38.92 $2.35 Million - $3.29 Million	-84,435 Reduced 1.72%	4,835,289 $725 Million
Q1 2019 May 01, 2019	SELL	$28.07 - $38.18 $271,745 - $369,620	-9,681 Reduced 0.2%	4,919,724 $0
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $4.45 Million - $6.16 Million	-164,792 Reduced 3.23%	4,929,405 $591 Million
Q3 2018 Nov 13, 2018	SELL	$23.35 - $36.72 $2.43 Million - $3.81 Million	-103,870 Reduced 2.0%	5,094,197 $729 Million
Q2 2018 Jul 17, 2018	SELL	$17.54 - $25.22 $3.85 Million - $5.54 Million	-219,757 Reduced 4.06%	5,198,067 $494 Million
Q1 2018 May 10, 2018	SELL	$13.06 - $18.54 $1.73 Million - $2.46 Million	-132,760 Reduced 2.39%	5,417,824 $402 Million
Q4 2017 Feb 13, 2018	SELL	$11.12 - $15.38 $2.52 Million - $3.49 Million	-227,050 Reduced 3.93%	5,550,584 $319 Million
Q3 2017 Oct 20, 2017	SELL	$11.36 - $18.98 $3.6 Million - $6.01 Million	-316,837 Reduced 5.2%	5,777,634 $283 Million
Q2 2017 Aug 10, 2017	BUY	N/A	6,094,471	6,094,471 $446 Million

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account

Baillie Gifford & CO Dexcom Inc Transaction History